trending Market Intelligence /marketintelligence/en/news-insights/trending/HPMb8YJUuOPZwkyslLDhFg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Valeant launches $1B debt offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Valeant launches $1B debt offering

Valeant Pharmaceuticals International Inc. launched a $1 billion debt offering to repurchase some of its existing notes.

Specifically, the company plans to repurchase its outstanding 5.375% senior notes, 7.00% senior notes and 6.375% senior notes, all due 2020.

The debt will be priced at a later date.

The company said it will also repay $175 million in outstanding amounts under its revolving credit facility in the week of Dec. 4 using available cash.

The notes will be guaranteed by each of Valeant's subsidiaries that are guarantors under the drugmaker's credit agreement and its existing senior notes.

Completion of the offering is subject to market and other conditions.